Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1133   
Active ingredient: Maribavir
Indication: Treatment of cytomegalovirus disease in patients with impaired cell mediated immunity
Sponsor: ViroPharma SPRL-BVBA
rue Montoyer 47, 1000 Bruxelles, Belgique / Montoyerstraat 47, 1000 Brussel, BelgiŽ

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Centralised Orphan - Designation EMA/OD/013/13 (2013)3668 of 07/06/2013